Literature DB >> 8063399

Pneumolysin activates phospholipase A in pulmonary artery endothelial cells.

J B Rubins1, T J Mitchell, P W Andrew, D E Niewoehner.   

Abstract

Pneumolysin has been identified as a virulence factor in Streptococcus pneumoniae disease. In addition to producing tissue injury through its cytolytic effect, pneumolysin might injure tissues indirectly by eliciting an inflammatory response. We demonstrate for the first time that pneumolysin is a rapid and potent activator of cellular phospholipase A in bovine pulmonary artery endothelial cells. In contrast to other toxin-activated phospholipases, pneumolysin-stimulated phospholipase A showed no substrate specificity among major cellular membrane phospholipids. Phospholipase A activation required the formation of functional transmembrane pores by pneumolysin rather than membrane lipid perturbation. Pneumolysin stimulation of phospholipase A was calcium dependent; however, pneumolysin did not appear to function simply as a calcium ionophore. Pneumolysin was capable of stimulating purified bee and snake venom phospholipase A2s against a phospholipid substrate isolated from endothelial cells. Thus, pneumolysin stimulates cellular phospholipase A and the resulting products might further injure tissues by direct cytolytic effect or by evoking inflammatory responses.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8063399      PMCID: PMC303037          DOI: 10.1128/iai.62.9.3829-3836.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  40 in total

1.  Expression of the pneumolysin gene in Escherichia coli: rapid purification and biological properties.

Authors:  T J Mitchell; J A Walker; F K Saunders; P W Andrew; G J Boulnois
Journal:  Biochim Biophys Acta       Date:  1989-01-23

2.  Phospholipases: melittin facilitation of bee venom phospholipase A2-catalyzed hydrolysis of unsonicated lecithin liposomes.

Authors:  R Yunes; A R Goldhammer; W K Garner; E H Cordes
Journal:  Arch Biochem Biophys       Date:  1977-09       Impact factor: 4.013

3.  Effect of Streptococcus pneumoniae on human respiratory epithelium in vitro.

Authors:  C Steinfort; R Wilson; T Mitchell; C Feldman; A Rutman; H Todd; D Sykes; J Walker; K Saunders; P W Andrew
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

4.  Permeability of the mammalian blood-gas barrier and its components.

Authors:  O D Wangensteen; L E Wittmers; J A Johnson
Journal:  Am J Physiol       Date:  1969-04

Review 5.  Phospholipase A2: function and pharmacological regulation.

Authors:  J Chang; J H Musser; H McGregor
Journal:  Biochem Pharmacol       Date:  1987-08-01       Impact factor: 5.858

Review 6.  Intracellular phospholipases A.

Authors:  H van den Bosch
Journal:  Biochim Biophys Acta       Date:  1980-09-30

7.  Capsular types and outcome of bacteremic pneumococcal disease in the antibiotic era.

Authors:  M A Mufson; D M Kruss; R E Wasil; W I Metzger
Journal:  Arch Intern Med       Date:  1974-09

8.  Pneumococcal bacteremia--no change in mortality in 30 years: analysis of 104 cases and review of the literature.

Authors:  M R Kramer; B Rudensky; I Hadas-Halperin; M Isacsohn; E Melzer
Journal:  Isr J Med Sci       Date:  1987-03

9.  Staphylococcal delta toxin stimulates endogenous phospholipase A2 activity and prostaglandin synthesis in fibroblasts.

Authors:  J P Durkin; W T Shier
Journal:  Biochim Biophys Acta       Date:  1981-02-23

10.  Increased sheep lung vascular permeability caused by pseudomonas bacteremia.

Authors:  K L Brigham; W C Woolverton; L H Blake; N C Staub
Journal:  J Clin Invest       Date:  1974-10       Impact factor: 14.808

View more
  17 in total

1.  Pneumolysin potentiates production of prostaglandin E(2) and leukotriene B(4) by human neutrophils.

Authors:  R Cockeran; H C Steel; T J Mitchell; C Feldman; R Anderson
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

2.  Induction of gamma interferon and nitric oxide by truncated pneumolysin that lacks pore-forming activity.

Authors:  Hisashi Baba; Ikuo Kawamura; Chikara Kohda; Takamasa Nomura; Yutaka Ito; Terumi Kimoto; Isao Watanabe; Satoshi Ichiyama; Masao Mitsuyama
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

3.  Pneumolysin-induced complement depletion during experimental pneumococcal bacteremia.

Authors:  R B Alcantara; L C Preheim; M J Gentry-Nielsen
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

4.  Reduced release of pneumolysin by Streptococcus pneumoniae in vitro and in vivo after treatment with nonbacteriolytic antibiotics in comparison to ceftriaxone.

Authors:  Annette Spreer; Holger Kerstan; Tobias Böttcher; Joachim Gerber; Alexander Siemer; Gregor Zysk; Timothy J Mitchell; Helmut Eiffert; Roland Nau
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

5.  Host cellular immune response to pneumococcal lung infection in mice.

Authors:  A Kadioglu; N A Gingles; K Grattan; A Kerr; T J Mitchell; P W Andrew
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

6.  Cytosolic Phospholipase A2α Promotes Pulmonary Inflammation and Systemic Disease during Streptococcus pneumoniae Infection.

Authors:  Rudra Bhowmick; Stacie Clark; Joseph V Bonventre; John M Leong; Beth A McCormick
Journal:  Infect Immun       Date:  2017-10-18       Impact factor: 3.441

Review 7.  Bacteria and endothelial cells: a toxic relationship.

Authors:  Ashira Lubkin; Victor J Torres
Journal:  Curr Opin Microbiol       Date:  2016-12-22       Impact factor: 7.934

8.  Upper and lower respiratory tract infection by Streptococcus pneumoniae is affected by pneumolysin deficiency and differences in capsule type.

Authors:  Aras Kadioglu; Sally Taylor; Francesco Iannelli; Gianni Pozzi; Tim J Mitchell; Peter W Andrew
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

Review 9.  The role of pneumolysin in pneumococcal pneumonia and meningitis.

Authors:  R A Hirst; A Kadioglu; C O'callaghan; P W Andrew
Journal:  Clin Exp Immunol       Date:  2004-11       Impact factor: 4.330

10.  Suilyin Disrupts the Blood-Brain Barrier by Activating Group III Secretory Phospholipase A2.

Authors:  Yutong Sui; Ying Chen; Qingyu Lv; Yuling Zheng; Decong Kong; Hua Jiang; Wenhua Huang; Yuhao Ren; Peng Liu; Yongqiang Jiang
Journal:  Life (Basel)       Date:  2022-06-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.